دورية أكاديمية

First report of the randomized phase III study of bi-weekly trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) vs. FTD/TPI monotherapy for chemorefractory metastatic colorectal cancer (mCRC): JCOG2014 (ROBiTS).

التفاصيل البيبلوغرافية
العنوان: First report of the randomized phase III study of bi-weekly trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV) vs. FTD/TPI monotherapy for chemorefractory metastatic colorectal cancer (mCRC): JCOG2014 (ROBiTS).
المؤلفون: Satake, Hironaga, Yamazaki, Kentaro, Suwa, Yusuke, Tsushima, Takahiro, Ishizuka, Yasunobu, Boku, Shogen, Takashima, Atsuo, Yamaguchi, Toshifumi, Asayama, Masako, Yokota, Mitsuru, Numata, Koji, Ohta, Takashi, Yasui, Hisateru, Kito, Yosuke, Takii, Yasumasa, Kitabayashi, Ryo, Sano, Yusuke, Fukuda, Haruhiko, Hamaguchi, Tetsuya, Kanemitsu, Yukihide
المصدر: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p118-118, 235p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2024.42.3_suppl.118